161 related articles for article (PubMed ID: 23770783)
1. Biorelevant solubility of poorly soluble drugs: rivaroxaban, furosemide, papaverine and niflumic acid.
Takács-Novák K; Szőke V; Völgyi G; Horváth P; Ambrus R; Szabó-Révész P
J Pharm Biomed Anal; 2013 Sep; 83():279-85. PubMed ID: 23770783
[TBL] [Abstract][Full Text] [Related]
2. Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media.
Fagerberg JH; Tsinman O; Sun N; Tsinman K; Avdeef A; Bergström CA
Mol Pharm; 2010 Oct; 7(5):1419-30. PubMed ID: 20507160
[TBL] [Abstract][Full Text] [Related]
3. Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents.
Kalantzi L; Persson E; Polentarutti B; Abrahamsson B; Goumas K; Dressman JB; Reppas C
Pharm Res; 2006 Jun; 23(6):1373-81. PubMed ID: 16715357
[TBL] [Abstract][Full Text] [Related]
4. The apparent solubilizing capacity of simulated intestinal fluids for poorly water-soluble drugs.
Schwebel HJ; van Hoogevest P; Leigh ML; Kuentz M
Pharm Dev Technol; 2011 Jun; 16(3):278-86. PubMed ID: 20214530
[TBL] [Abstract][Full Text] [Related]
5. Solubility profiling of HIV protease inhibitors in human intestinal fluids.
Wuyts B; Brouwers J; Mols R; Tack J; Annaert P; Augustijns P
J Pharm Sci; 2013 Oct; 102(10):3800-7. PubMed ID: 23939880
[TBL] [Abstract][Full Text] [Related]
6. Ethanol effects on apparent solubility of poorly soluble drugs in simulated intestinal fluid.
Fagerberg JH; Al-Tikriti Y; Ragnarsson G; Bergström CA
Mol Pharm; 2012 Jul; 9(7):1942-52. PubMed ID: 22651218
[TBL] [Abstract][Full Text] [Related]
7. Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids.
Clarysse S; Brouwers J; Tack J; Annaert P; Augustijns P
Eur J Pharm Sci; 2011 Jul; 43(4):260-9. PubMed ID: 21570465
[TBL] [Abstract][Full Text] [Related]
8. Bile Salt Micelles and Phospholipid Vesicles Present in Simulated and Human Intestinal Fluids: Structural Analysis by Flow Field-Flow Fractionation/Multiangle Laser Light Scattering.
Elvang PA; Hinna AH; Brouwers J; Hens B; Augustijns P; Brandl M
J Pharm Sci; 2016 Sep; 105(9):2832-2839. PubMed ID: 27103012
[TBL] [Abstract][Full Text] [Related]
9. Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3.
Fuchs A; Leigh M; Kloefer B; Dressman JB
Eur J Pharm Biopharm; 2015 Aug; 94():229-40. PubMed ID: 26032292
[TBL] [Abstract][Full Text] [Related]
10. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
Arndt M; Chokshi H; Tang K; Parrott NJ; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
[TBL] [Abstract][Full Text] [Related]
11. Importance of critical micellar concentration for the prediction of solubility enhancement in biorelevant media.
Ottaviani G; Wendelspiess S; Alvarez-Sánchez R
Mol Pharm; 2015 Apr; 12(4):1171-9. PubMed ID: 25665011
[TBL] [Abstract][Full Text] [Related]
12. Simulating fasted human intestinal fluids: understanding the roles of lecithin and bile acids.
Söderlind E; Karlsson E; Carlsson A; Kong R; Lenz A; Lindborg S; Sheng JJ
Mol Pharm; 2010 Oct; 7(5):1498-507. PubMed ID: 20698569
[TBL] [Abstract][Full Text] [Related]
13. Cocrystal Solubilization in Biorelevant Media and its Prediction from Drug Solubilization.
Lipert MP; Roy L; Childs SL; Rodríguez-Hornedo N
J Pharm Sci; 2015 Dec; 104(12):4153-4163. PubMed ID: 26390213
[TBL] [Abstract][Full Text] [Related]
14. Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid.
McPherson S; Perrier J; Dunn C; Khadra I; Davidson S; Ainousah B; Wilson CG; Halbert G
Eur J Pharm Biopharm; 2020 May; 150():14-23. PubMed ID: 32035969
[TBL] [Abstract][Full Text] [Related]
15. Topography of Simulated Intestinal Equilibrium Solubility.
Dunn C; Perrier J; Khadra I; Wilson CG; Halbert GW
Mol Pharm; 2019 May; 16(5):1890-1905. PubMed ID: 30848917
[TBL] [Abstract][Full Text] [Related]
16. The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids.
Persson EM; Gustafsson AS; Carlsson AS; Nilsson RG; Knutson L; Forsell P; Hanisch G; Lennernäs H; Abrahamsson B
Pharm Res; 2005 Dec; 22(12):2141-51. PubMed ID: 16247711
[TBL] [Abstract][Full Text] [Related]
17. Determination of protonation macro- and microconstants and octanol/water partition coefficient of the antiinflammatory drug niflumic acid.
Takács-Novák K; Avdeef A; Box KJ; Podányi B; Szász G
J Pharm Biomed Anal; 1994 Nov; 12(11):1369-77. PubMed ID: 7849133
[TBL] [Abstract][Full Text] [Related]
18. The impact of reduced gastric acid secretion on dissolution of salts of weak bases in the fasted upper gastrointestinal lumen: Data in biorelevant media and in human aspirates.
Litou C; Vertzoni M; Xu W; Kesisoglou F; Reppas C
Eur J Pharm Biopharm; 2017 Jun; 115():94-101. PubMed ID: 28214603
[TBL] [Abstract][Full Text] [Related]
19. Biorelevant Drug Solubility Enhancement Modeled by a Linear Solvation Energy Relationship.
Niederquell A; Kuentz M
J Pharm Sci; 2018 Jan; 107(1):503-506. PubMed ID: 28864357
[TBL] [Abstract][Full Text] [Related]
20. Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugs.
Zhou Z; Dunn C; Khadra I; Wilson CG; Halbert GW
Eur J Pharm Sci; 2017 Mar; 99():95-104. PubMed ID: 27940083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
